Skip to content
Insider tapeFilings through Fri, Oct 9
Watchlist
ENTA

ENANTA PHARMACEUTICALS (ENTA) stock: insider trades, news & valuation

Heavy selling
Close · Oct 9, 2026 $12.50 +3.3% on the day +9.1% over 12 months 52-week range $10.47 – $16.85

Share price and insider trades

ENTA closeInsider buyInsider sale
1012141618NovDecJan 2026FebMarAprMayJunJulAugSepOctSold $8,195 on 2025-12-02 · Harry R. Trout III, Kathleen S. CappsSold $174,972 on 2025-12-05 · Brendan Luu, Harry R. Trout III, Jay R. Luly, Kathleen S. Capps, Scott T. Rottinghaus, Tara Lynn Kieffer, Yat Sun Or
Bought, 12 months$0
Sold, 12 months$183K
Insiders buying0
Insiders selling7

ENANTA PHARMACEUTICALS insider trading at a glance (Oct 9, 2026): in the past 12 months, 0 insiders bought $0 and 7 sold $183K of ENTA stock on the open market.

ENTA insider buying and selling by quarter

Open-market purchases (green, above the line) and sales (red, below), by trade date.

Q4 2025: $183K sold (9 trades)Q4 2025Q1 2026Q2 2026Q3 2026Q4 2026
QuarterBoughtPurchasesSoldSales
Q4 2026—0—0
Q3 2026—0—0
Q2 2026—0—0
Q1 2026—0—0
Q4 2025—0$183K9

Valuation, profit and volume

P/E (trailing)n/aSector median —
Market value— 
Profit margin—Revenue growth —
Volume vs. 50-day0.9×Last 5 sessions
Insiders' paper profit—On all tracked purchases —

Summary

Over the past 12 months, 0 ENANTA PHARMACEUTICALS INC insiders reported open-market purchases totaling $0, while 7 insiders reported sales totaling $183K. 0 of 9 recorded sales were made under pre-scheduled Rule 10b5-1 trading plans, which are usually less informative than discretionary sales.

Insider transactions

Open-market purchases and sales.

Filed Insider Type Shares Price Value Since Score
Dec 5SEC Jay R. LulyCEO, President Sell 4,743858,026 held (−1%) $14.23 $67K -12.2% —
Dec 5SEC Yat Sun OrChief Scientific Officer Sell 2,390371,392 held (−1%) $14.23 $34K -12.2% —
Dec 5SEC Tara Lynn KiefferChief Product Strategy Officer Sell 2,10630,620 held (−6%) $14.23 $30K -12.2% —
Dec 5SEC Brendan LuuChief Business Officer Sell 1,39438,329 held (−4%) $14.23 $20K -12.2% —
Dec 5SEC Scott T. RottinghausChief Medical Officer Sell 79821,792 held (−4%) $14.23 $11K -12.2% —
Dec 5SEC Harry R. Trout IIISee Remarks Sell 54216,348 held (−3%) $14.23 $8K -12.2% —
Dec 5SEC Kathleen S. CappsSee Remarks Sell 3238,377 held (−4%) $14.23 $5K -12.2% —
Dec 3SEC Harry R. Trout IIISee Remarks Sell 38016,890 held (−2%) $13.96 $5K -10.5% —
Dec 3SEC Kathleen S. CappsSee Remarks Sell 2078,700 held (−2%) $13.96 $3K -10.5% —

Insiders at ENANTA PHARMACEUTICALS INC

InsiderBoughtSoldLast filingScore
Jay R. LulyCEO, President — $67K Dec 5, 2025 —
Yat Sun OrChief Scientific Officer — $34K Dec 5, 2025 —
Tara Lynn KiefferChief Product Strategy Officer — $30K Dec 5, 2025 —
Brendan LuuChief Business Officer — $20K Dec 5, 2025 —
Harry R. Trout IIISee Remarks — $13K Dec 5, 2025 —
Scott T. RottinghausChief Medical Officer — $11K Dec 5, 2025 —
Kathleen S. CappsSee Remarks — $7K Dec 5, 2025 —

ENTA stock: common questions

Are ENANTA PHARMACEUTICALS INC insiders buying ENTA stock?

In the past 12 months, 0 insiders reported open-market purchases of ENTA worth $0.

Are ENANTA PHARMACEUTICALS INC insiders selling ENTA stock?

7 insiders reported sales worth $183K over the same period.

Where does this data come from?

Every transaction comes from Form 4 filings that insiders must submit to the SEC within two business days of a trade. We pull them from SEC EDGAR every night.

What is ENTA's 52-week range?

Over the past year ENTA has traded between $10.47 and $16.85. It last closed at $12.50 on Oct 9, 2026.